Reyva (formerly Qorium)
Reyva (formerly Qorium) grows real leather from cells, exceptional in look, feel and performance. Its cultivated leather comes with a fraction of the environmental impact of traditional hides. A 2024 lifecycle analysis by CE Delft found that Reyva leather produces 87% less CO2-eq, uses 98% less land and 86% fewer tanning chemicals than calf leather.
Sector
Industrial Biotech
Strategy
Industrial Biotech
Status
Live
Website
www.reyva.com
Related News
Qorium secures €22M to scale cultivated leather production
Bio-engineering scale-up Qorium showcases cultivated leather breakthrough, signaling a key step towards commercialisation
Qorium bolsters Board with appointment of Elizabeth Bastoni and Martin Brok, renowned experts in the consumer goods and retail sectors
Qorium lands additional funds from Brightlands Venture Partners and Sofinnova Partners, as the company sets out on an ambitious growth drive for sustainable leather with the appointment of CEO Michael Newton
SofinnovaCapital
The Sofinnova Capital Strategy is our flagship fund, investing as founding or lead investor in early-stage biopharma and medtech start-ups developing groundbreaking therapeutic technologies.
SofinnovaMD Start
The Sofinnova MD Start Strategy is our in-house medtech accelerator focused on creating and launching early-stage medtech companies through hands-on company building.
SofinnovaCrossover
The Sofinnova Crossover Strategy invests in growth-stage biotech and medtech companies that have clinically validated their technologies and are preparing for commercialization.
SofinnovaIndustrial Biotech
Our Industrial Biotech Strategy invests in early-stage sustainable companies across the agriculture, chemicals, food and materials sectors.
SofinnovaTelethon
The Sofinnova Telethon Strategy makes early-stage investments in leading Italian science for the benefit of patients around the world.
SofinnovaDigital Medicine
Our Digital Medicine Strategy backs early-stage techbio and healthtech start-ups at the intersection of biology, data, and computation.
SofinnovaBiovelocita
The Sofinnova Biovelocita Strategy is our biotech accelerator, partnering with leading research organizations to create and build European biotech start-ups.